Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about James A/ Mish
Recent news which mentions James A/ Mish
22nd Century Appoints Interim CEO, Implements $15M Cost Reduction Initiative
July 24, 2023
Tickers
XXII
Tags
News
Markets
James A/ Mish
From
Benzinga
22nd Century To Secure $3M Via Registered Direct Offering Priced Above Market
July 07, 2023
Tickers
XXII
Tags
News
XXII
Market News
From
Benzinga
22nd Century Group Q1 2023 Revenue Grows 142% YoY, What About Adjusted EBITDA?
May 09, 2023
Tickers
XXII
Tags
Cannabis
Markets
James A/ Mish
From
Benzinga
22nd Century Group Signs Exclusive License And Distribution Agreement With Cookies
April 05, 2023
Tickers
XXII
Tags
News
cookies
XXII
From
Benzinga
22nd Century Group Q4 2022 Net Revenue Grows 141.3% YoY, What About Profit?
March 09, 2023
Tickers
XXII
Tags
Markets
Cannabis
Market News
From
Benzinga
22nd Century Group Secures $21M Debt Financing For Accelerated Expansion
March 06, 2023
Tickers
XXII
Tags
XXII
News
Penny Stocks
From
Benzinga
22nd Century Group Acquires RX Pharmatech, Files U.S. Drug Master File For CBD API, Teams Up With Transo-Pharm
January 24, 2023
Tickers
XXII
Tags
News
M&A
James A/ Mish
From
Benzinga
22nd Century Group's GVB Biopharma Opens New Cannabis Distribution Facility In The Netherlands
November 17, 2022
Tickers
XXII
Tags
News
XXII
Market News
From
Benzinga
22nd Century Group Q3 Revenue Grows 148% YoY, Here Are The Details
November 08, 2022
Tickers
XXII
Tags
Market News
James A/ Mish
Markets
From
Benzinga
22nd Century Group Acquires Privately-Held Cannabis & Hemp Co., Here's What's Next
May 13, 2022
Tickers
CBD
HEMP
XXII
Tags
Benzinga
GVB Biopharma
Penny Stocks
From
Benzinga
22nd Century Group Reports Q1 Net Sales Of $9M, Up 33% YoY, Net Loss Also Grows
May 05, 2022
Tickers
BAYRY
XXII
Tags
News
Earnings
Brian Wright
From
Benzinga
FDA-Authorized Reduced-Nicotine Cigarette From 22nd Century Group That 'Helps You Smoke Less' To Reach Illinois
March 28, 2022
Tickers
XXII
Tags
Benzinga
Market News
James A/ Mish
From
Benzinga
22nd Century Group To Host Q4 & FY 2021 Earnings Call
February 03, 2022
Tickers
XXII
Tags
Earnings
News
Richard Fitzgerald
From
Benzinga
Aurora Cannabis, 22nd Century Group To License Biosynthesis Intellectual Property To Cronos
December 15, 2021
Tickers
ACB
CRON
XXII
Tags
Cannabis
Market News
Benzinga
From
Benzinga
Cannabis Movers & Shakers: Leafly, Origin Therapeutics, ECGI Holdings, 22nd Century Group
November 26, 2021
Tickers
ECGI
FMANF
MCMJ
SPRWF
Tags
News
Entrepreneurship
Movers & Shakers
From
Benzinga
22nd Century Group Reports Revenue Gains In Q3, Seeks To Monetize Its Hemp & Cannabis Plant Lines
November 04, 2021
Tickers
ACB
XXII
Tags
third quarter earnings
XXII
Small Cap
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.